VENDOR PROFILE · AI SCRIBES · CLOUD
Suki
A voice-first ambient AI assistant that integrates deeply with all four major U.S. EHRs — Epic, Oracle Health, athenahealth, and MEDITECH — with the broadest specialty coverage in the category and the only meaningful MEDITECH Expanse footprint among major commercial scribes. The right reference for buyers on MEDITECH and for teams that want voice commands alongside the ambient note.
Customers since inception. Anchor account: MedStar Health, a $7.7B system with 300+ care locations, where Suki Assistant is live across thousands of clinicians.
Bidirectional integrations with Epic, Oracle Health (Cerner), athenahealth, and MEDITECH. The only major commercial scribe with a deep MEDITECH Expanse surface.
Broadest specialty coverage in the ambient-AI category. 80 languages supported. ~70% adoption rate among clinicians within deployed orgs (vendor-reported).
Closed October 2024, led by Hedosophia with Venrock, March Capital, Flare Capital, Breyer Capital, and inHealth Ventures. Total raised: $165M.
What Suki actually does
Suki is two products under one platform. Suki Compose is the ambient documentation app — a clinician records the encounter, Suki generates the note. Suki Assistant is the same plus deep bidirectional EHR integration: pull problem lists, vitals, allergies, and labs into the draft, and write finalized notes, orders, and codes back into the chart. The Assistant tier is also where the voice-command surface lives — clinicians can query the chart, navigate, and stage orders by voice.
Captures the encounter and synthesizes a complete note plus patient instructions. "Evidence-linked" documentation flags claims back to passages in the transcript to reduce hallucination and bias.
Voice-first chart navigation, clinical Q&A, and order staging. The differentiator versus the rest of the ambient-scribe field, which is documentation-only.
ICD-10 and E/M coding suggestions inline with the documentation. KLAS ROI validations cite material incremental revenue per provider per month tied to the coding surface.
Launched as a consortium-driven product in October 2025 with McLeod Health, Citizens Memorial, Boone Health, and Fisher-Titus shaping the requirements. Nursing-specific documentation flows distinct from physician notes.
Deployment posture
Cloud SaaS, sold per-user, with the most published price-band transparency in the commercial-scribe category. The differentiating posture is the EHR breadth: where most major scribes lead with Epic and treat the others as also-rans, Suki invests deeply in MEDITECH Expanse integration in particular — which is why the company has been the obvious choice for the 12+ health systems that adopted it primarily through the MEDITECH route.
Epic, Oracle Health, athenahealth, and MEDITECH Expanse. MEDITECH Expanse integration is the deepest non-Epic surface in the category — Suki Assistant for MEDITECH includes voice across any field.
SOC 2 Type 2 + HIPAA + BAA. TLS 1.2 in transit, AES-256 at rest. Evidence-linked documentation pattern: every draft claim is linked back to a transcript passage clinicians can audit before signing.
Suki Compose: $299 per user per month (documentation app). Suki Assistant: $399 per user per month (deep EHR integration tier). Among the most transparent pricing pages in the category.
MedStar Health, FMOL Health, McLeod Health, plus 12+ MEDITECH-led deployments. Adoption rate ~70% among clinicians in deployed orgs (vendor-reported).
The evidence base
Suki's evidence story leans on KLAS ROI validations and named-customer case studies more than peer-reviewed RCTs:
- checkKLAS ROI validation (2026) — Independent KLAS reports cite significant reductions in after-hours documentation and meaningful incremental revenue per provider at surveyed health systems. Treat as third-party evidence, not vendor self-report.
- check$1,688 per user per month incremental revenue — Vendor-reported figure based on coding-accuracy gains and clinician time freed up. This is the benchmark Suki uses in CFO conversations; treat as upper-bound and pressure-test against your own coder workflow.
- checkMedStar Health deployment — Suki Assistant rolled out across MedStar's ambulatory specialties including primary care, cardiology, and gastroenterology. Public reference point for system-wide adoption at a $7.7B system.
- closePeer-reviewed RCT evidence is thinner than Nabla's or Abridge's. If your evaluation rubric weights NEJM-level published evidence heavily, weight that gap — Suki's case is built on KLAS validation plus customer stories rather than independent RCTs.
Privacy and compliance posture
HIPAA-compliant, SOC 2 Type 2 certified, signs a BAA, encrypts data with TLS 1.2 in transit and AES-256 at rest. The product-level privacy investment that stands out is the "evidence-linked documentation" pattern — every claim in the AI-generated draft links back to a passage in the transcript clinicians can audit before signing. That is good practice for hallucination reduction, and it doubles as a defensible audit-log story for compliance officers reviewing how AI-generated content lands in the chart.
Like the rest of the cloud-scribe field, Suki processes audio off-prem. For most U.S. health systems already operating cloud-side under signed BAAs — including those on MEDITECH — this is normal procurement. For Canadian provincial settings or any buyer who needs PHI to remain inside the hospital network, the cloud path is the binding constraint regardless of how good Suki's evidence-linking is.
Strengths and limitations, plainly
Deepest MEDITECH Expanse integration in the category — most credible answer for MEDITECH-anchored systems. Voice-command surface beyond just documentation. Broadest specialty coverage (100+) and 80 languages. Published per-user pricing — easier to size a pilot. Evidence-linked documentation pattern is a real anti-hallucination move. KLAS ROI validation is third-party.
Cloud-only. Peer-reviewed RCT evidence is thinner than Abridge's or Nabla's. Total funding is mid-pack ($165M) versus the category's billion-dollar leaders. Voice-first UX, while distinctive, requires clinician comfort with spoken commands — adoption depends on workflow fit, not just feature presence.
Where Suki fits versus an on-prem alternative
| Dimension | Suki (cloud SaaS) | On-prem (WalledCare) |
|---|---|---|
| EHR sweet spot | All four majors. Best non-Epic option for MEDITECH Expanse. | HL7/FHIR + sidecar. Strong for MEDITECH and non-Epic EHRs (Oscar, Meditech, custom). |
| Voice commands | Yes — voice-first across documentation, navigation, Q&A. | Buildable, not out-of-the-box. The on-prem case is documentation + retrieval, not voice-driven UI. |
| Pricing | $299–$399 per user per month, published. | Capex + ops; no per-seat ramp. |
| Data residency | Cloud. Audio and transcripts leave the hospital network. | Inside the hospital data center; no outbound API. |
| Evidence-linking | Built-in. Every draft claim cites a transcript passage. | Built into the customer's stack: Self-RAG with citations on a vector index of customer-approved sources. |
| Specialty + language | 100+ specialties, 80 languages. | Built per customer; specialty depth is a configuration choice. |
Suki is the right answer when the EHR is MEDITECH Expanse, the budget can stomach $300–$400 per user per month, and the team wants voice commands plus the note. The on-prem path is the right answer when residency is the constraint and a multi-app local stack is the deployment goal.
Where this fits in the WalledCare directory
Suki is the strongest reference for the voice-first and MEDITECH framings of AI Scribes. If your team is on MEDITECH Expanse, Suki is the only major commercial scribe with a deep native surface there, and it should anchor the shortlist. If the framing is "we want a multi-app on-prem clinical AI stack — scribe, document Q&A, discharge, handoff — running inside our network," read our on-prem reference stack first.
Quick facts
| Founded | 2017, Redwood City, CA. Founder/CEO: Punit Soni (formerly Flipkart, Google). |
| Category | AI Assistant: ambient documentation + voice commands + ICD-10/E/M coding + chart Q&A. |
| Deployment | Cloud SaaS only. SOC 2 Type 2, HIPAA, BAA. TLS 1.2 in transit, AES-256 at rest. |
| Primary EHRs | Bidirectional with Epic, Oracle Health (Cerner), athenahealth, and MEDITECH Expanse — the deepest MEDITECH Expanse surface in the category. |
| Reference customers | MedStar Health, FMOL Health, McLeod Health. 12+ MEDITECH-led deployments. Suki for Nurses consortium: McLeod, Citizens Memorial, Boone Health, Fisher-Titus. |
| Coverage | 100+ specialties (broadest in category). 80 languages. ~70% adoption rate among clinicians in deployed orgs (vendor-reported). |
| Pricing | Suki Compose $299/user/month. Suki Assistant $399/user/month. |
| Funding | $165M total. $70M Series D October 2024 (Hedosophia lead). Investors: Venrock, March Capital, Flare Capital, Breyer Capital, inHealth Ventures. |
| Recognition | 2026 KLAS ROI validation reports cite reductions in after-hours documentation and incremental revenue per provider. |
| Website | suki.ai · EHR integrations: suki.ai/ehr-integrations |
Use Suki as the benchmark, then decide
If the deciding factor is "MEDITECH Expanse, voice commands, transparent per-user pricing," Suki belongs at the top of the shortlist. If the deciding factor is "audio and data cannot leave our network," WalledCare's on-prem stack is the alternative built for that.
Further reading
- Suki — product home
- Suki for Clinicians — documentation, coding, Q&A
- Suki EHR integrations — Epic, athenahealth, Oracle, MEDITECH
- Suki Compose — ambient documentation + ICD-10 coding
- Suki deploys at 12+ health systems via MEDITECH integration
- Suki Series D announcement and MedStar Health partnership
- Fierce Healthcare: Suki Series D and EHR partnerships
- Healthcare Dive: Suki Series D funding
- Suki: 2025 in review — ambient clinical intelligence
- Medical Economics on Suki Series D and program expansions